Boston Marathon Winner Grigoryeva Joins Athletes Banned for Doping

The IAAF on Wednesday released a list of athletes banned under the biological passport program.

Published
Sports
1 min read
Banned athlete Lidiya Grigoryeva has won the Boston marathon and the Chicago marathon. (Photo: Reuters)

Former Boston Marathon winner Lidiya Grigoryeva has been banned for two and a half years for doping.

The International Association of Athletic Federations (IAAF) says the 42-year-old Grigoryeva, who won the Boston Marathon in 2007 and the Chicago Marathon in 2008, was banned under the biological passport program, which tracks suspicious blood parameters over a long period.

Grigoryeva, a Russian citizen, was also a European bronze medalist in the 10,000 meters in 2006.

The IAAF also announced a ban of two and a half years for another Russian, distance runner Alyona Kudashkina. She is reportedly a former pupil of Viktor Chegin, a coach linked to more than 25 doping cases, mostly in race-walking.

Moroccan runner Amine Laalou was also among the athletes whose doping bans were confirmed by the IAAF on Wednesday. (Photo: Reuters)
Moroccan runner Amine Laalou was also among the athletes whose doping bans were confirmed by the IAAF on Wednesday. (Photo: Reuters)

There is also a four-year ban for Russian middle-distance runner Larisa Kleimenova, who tested positive at last year’s Russian relay championships.

Moroccan middle-distance runner Amine Laalou was also among the athletes whose doping bans were confirmed by the IAAF on Wednesday.

The 34-year-old Laalou, a silver medalist at the 2010 African championships in the 1,500 meters, was banned for eight years for his second doping offense after failing an out-of-competition test in Morocco in April.

Laalou previously served a two-year ban between 2012-14 after testing positive for the diuretic and masking agent furosemide. His latest ban runs until May 2024.

(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!